Thiamine Deficiency and Associated Clinical Disorders

2009
ISBN: 978-1-61779-637-1
Verlag: Humana Press

Buch, Englisch, 192 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 324 g

Reihe: Contemporary Clinical Neuroscience

Thiamine deficiency and related clinical disorders represent an intriguing area of both basic and clinical investigation. Modern imaging strategies have facilitated the rapid treatment, and potential reversal of these clinical disorders. The fusion of laboratory and clinical knowledge serve as an example of how research can translate to successful treatment. The goal of Thiamine Deficiency and Related Clinical Disorders is to bring together cogent results from basic and clinical investigation and to stimulate further investigations in these areas. This data will be useful to neurologists, internists, nutritionists, biochemists, neurochemists, neuroscientists, and others with interest in thiamine deficiency.

Zielgruppe

Research

Autoren/Hrsg.

McCandless, David W.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Ernährungsmedizin, Diätetik

Inhaltsverzeichnis

Early Chemistry.- Early Thiamine Deficiency.- Thiamine Deficiency in Mammals.- Beriberi.- Wernicke’s Disease.- Central Pontine Myelinolysis, Alcoholic Cerebellar Degeneration, and Marchiafava–Bignami Disease.- Leigh’s Disease.- African Seasonal Ataxia.- Inherited Ataxias.- Thiamine Deficiency in Serious Illness.- World Health Concerns.- Epilogue: Future Prospects.

Über Autor(innen)

Dr. David W. McCandless is the John J. Sheinin Professor of Anatomy in the Department of Cell Biology and Anatomy at The Chicago Medical School, Rosalind Franklin University, North Chicago, IL, USA. He has over 35 years of laboratory research into basic mechanisms of various metabolic encephalopathies. He serves as Editor-in Chief of the journal Metabolic Brain Disease (Springer), now in its 25th year. Dr. McCandless has been on the faculty or research staff at The University of Vermont College of Medicine, NIH-NINCDS, University of Texas Medical School at Houston, and The Chicago Medical School, and was a visiting professor at Washington University School of Medicine. Dr. McCandless has published in journals such as The J. Clinical Investigation, Nature, Proc. National Academy of Sciences, Amer. J. of Physiology, Brain Research, J. Neurochemistry, Teratology, Epilepsia, Stroke, and many others.